8-K: FitLife Brands Q4 2025 Earnings Call Transcript

FitLife Brands discusses Q4 and full-year 2025 financial results, highlighting the impact of the Irwin Naturals acquisition and strategies to address market headwinds.

Summary

• FitLife Brands reported on its fourth quarter and full year 2025 financial results during an earnings call on April 1, 2026.
• The acquisition of Irwin Naturals, completed on August 8, 2025, significantly impacted the financial results, contributing to a 73% increase in total revenue for Q4 2025.
• Legacy FitLife brands (excluding MRC and MusclePharm) showed organic revenue growth of 6% for the full year 2025, with online revenue up 16%.
• MusclePharm reported 5% organic revenue growth for 2025, while MRC revenue declined by 15%.
• Irwin Naturals, after normalizing for discontinued products (CBD) and customers (Costco U.S., Rite Aid), showed flat net revenue from 2024 to 2025, but achieved 6% organic growth in Q4 2025.
• The company is implementing five key priorities to address recent soft performance, including improving Irwin's supply chain, focusing on new product development at Irwin, driving off-Amazon demand generation, leveraging Irwin's sales team for cross-selling, and optimizing SG&A.
• FitLife Brands is ahead of schedule on debt reduction, having paid down approximately $1.9 million in Q4 2025 and an additional $1.5 million in Q1 2026.
• The company is holding off on providing formal 2026 guidance due to current market weakness and uncertainty about the persistence of exogenous challenges and the timing of internal initiatives.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral sentiment. While the Irwin acquisition boosted revenue and Adjusted EBITDA, significant challenges remain with declining Legacy FitLife performance, margin pressures, and adapting to e-commerce shifts.

Positives

• Legacy FitLife brands (excluding MRC and MusclePharm) achieved 6% organic revenue growth for the full year 2025.
• Online revenue for Legacy FitLife increased by approximately 16% in 2025.
• MusclePharm showed 5% organic revenue growth in 2025.
• Irwin Naturals achieved 6% organic growth in Q4 2025 when normalized for specific customer and product changes.
• Total revenue increased by 73% in Q4 2025, largely due to the Irwin Naturals acquisition.
• Wholesale revenue increased by 213% in Q4 2025, driven by the Irwin acquisition.
• Adjusted EBITDA increased by 14% in Q4 2025.
• Irwin's online business is growing, with monthly revenue reaching approximately $0.8 million in March 2026, indicating a run rate of $9-10 million annually.
• Irwin's subscriber growth on Amazon is strong, increasing from approximately 500 to over 3,600.
• The company is ahead of schedule on debt reduction, having paid down $1.9 million in Q4 2025 and $1.5 million in Q1 2026.

Negatives

• MRC revenue declined by approximately 15% in 2025.
• Legacy FitLife total revenue decreased by 12% in Q4 2025, with wholesale down 14% and online down 10%.
• Gross margin declined to 37.0% in Q4 2025 from 41.4% in Q4 2024, primarily due to the lower-margin Irwin acquisition.
• Net income decreased to $1.6 million in Q4 2025 from $2.1 million in Q4 2024, impacted by acquisition-related expenses.
• The company is experiencing broad-based weakness across most brands and channels in Q1 2026, with pacing slightly down compared to Q4 2025.
• Irwin's historical financials were impacted by the discontinuation of products at Costco U.S. and Rite Aid's bankruptcy.
• The company is discontinuing all CBD products from Irwin due to legal complexities and declining sales.
• Subscriber counts are declining across most of FitLife's brands on Amazon, attributed to a change in Amazon's default purchase option from 'subscribe and save' to 'onetime purchase'.

Risks

• Continued broad-based consumer confidence concerns and declining discretionary spending due to economic and political volatility.
• Challenges in the protein market impacting MusclePharm's performance and profitability.
• Potential for continued stock-outs at Irwin due to supply chain issues.
• The evolving dynamics of Amazon's algorithms (shift from A9 to A10) prioritizing external traffic and organic engagement, impacting brand visibility.
• Difficulty in regaining distribution with major retailers like Costco U.S. after prior discontinuation.
• Uncertainty regarding the duration of current market weakness and the speed at which internal initiatives will yield positive results.
• The complexity and evolving nature of state-level regulations for selling CBD products.
• Potential for increased costs associated with revising product formulas to achieve three-year shelf life.

Future Outlook

The company is not providing formal guidance for the full year 2026 due to current market weakness and uncertainty about how long these challenges will persist and how quickly internal efforts will yield results. The online growth at Irwin is encouraging, but it is unclear if it will fully offset weakness elsewhere. Q1 2026 is pacing slightly down compared to Q4 2025.

Management Comments

• "2025 was a strong year for all of our brand groupings other than MRC, whose challenges we have discussed previously."
• "We are excited about the Irwin acquisition, which happened in August of last year."
• "If we remove Costco U.S., CBD and Rite Aid from the financials, Irwin's net revenue for the full-year of 2024 would have been $54 million, and its revenue for the full-year of 2025 would have been $54 million. In other words, if you normalize the numbers to reflect the customers and products that represent the go-forward business, the brand was flat from 2024 to 2025."
• "We expect to be able to significantly improve Irwin's supply chain."
• "Dramatically reducing this inventory obsolescence has the potential to increase Irwin's gross margins by as much as 300 to 400 basis points with a corresponding dollar-for-dollar impact on EBITDA."
• "We believe a significant part of the weakness we are experiencing on Amazon relates to continued evolution of the Amazon algorithms."
• "We are ahead of schedule on our debt reduction, and will continue to deploy excess free cash flow to further reduce indebtedness."
• "For those of you who are interested in the evolving dynamics of e-commerce marketplaces, I would encourage you to Google the recent shift from Amazon's A9 algorithm to what the Amazon community refers to as the A10 algorithm."
• "Our intention is to grow [MusclePharm]. But the thought that we could buy it and just get back into everyone that used to sell it from Walmart to Costco U.S. to everybody else, it didn't happen, and not for lack of trying."
• "In hindsight, well, I will never buy another brand that is IP only, and I will never buy another brand that is protein-dominant just given kind of what we've seen and what we experienced."

Industry Context

StockSavvy.ai notes that FitLife Brands is navigating a challenging market characterized by declining consumer discretionary spending and evolving e-commerce dynamics, particularly on Amazon. The company's strategies, such as improving supply chain efficiency for Irwin Naturals and adapting to Amazon's algorithm changes, are critical for future performance in the competitive nutritional supplement industry.

Comparison to Industry Standards

• The decline in gross margin to 37.0% in Q4 2025 from 41.4% in Q4 2024 is noted, with the company aiming to improve Irwin's margins from the low 30s into the mid-to-high 30s, and the combined business towards the high 30s over time.
• Legacy FitLife brands historically operated in the low 40s for gross margin.
• The company aims to reduce Irwin's inventory obsolescence, which historically disposed of approximately $2 million annually, by transitioning to a three-year shelf life, potentially increasing gross margins by 300-400 basis points.
• The shift in Amazon's algorithm from A9 to A10, prioritizing external traffic and organic engagement, is a significant industry trend impacting online sales performance for many brands, not just FitLife.
• The protein market, a significant segment for MusclePharm, is experiencing high input costs, with whey protein concentrate at $11 per pound, impacting profitability.

Legal Proceedings

• Rite Aid, a major customer for Irwin, went into bankruptcy and liquidation prior to the acquisition.

Stakeholder Impact

• Shareholders: The acquisition of Irwin Naturals has increased revenue and Adjusted EBITDA, but ongoing market weakness and integration challenges may impact future profitability and stock performance.
• Employees: The company is optimizing SG&A, including exiting office leases, which could impact employees in those locations. Hiring of new roles (VP of Operations for Irwin, CMO) indicates investment in key areas.
• Suppliers: Efforts to improve Irwin's supply chain and shelf-life management aim to create more stable demand and reduce inventory write-offs, potentially benefiting suppliers through more consistent orders.
• Creditors: The company is ahead of schedule on debt reduction, which is positive for creditors as it reduces financial risk.

Next Steps

• Continue to implement five key priorities to address soft performance: improve Irwin's supply chain, focus on new product development at Irwin, drive off-Amazon demand generation, leverage Irwin's sales team for cross-selling, and optimize SG&A.
• Transitioning products to a three-year shelf life to reduce obsolete inventory write-offs.
• Launch three new Irwin products in the third quarter of 2026.
• Expand off-Amazon marketing efforts across key brands, including Dr. Tobias and Irwin.
• Continue to look for SG&A efficiencies, such as optimizing office leases.
• Continue to deploy excess free cash flow to further reduce indebtedness.
• Potentially announce additional distribution gains in future earnings calls.
• Expect to have more concrete information on MusclePharm's distribution gains for the next earnings call.

Key Dates

Recommendation

The company's revenue has increased due to a significant acquisition, and it is actively addressing operational challenges and market shifts. However, the persistent weakness in legacy brands, margin pressures, and uncertainty regarding the full-year outlook warrant a cautious 'hold' rating until the effectiveness of the implemented strategies becomes clearer.

Keywords

FitLife Brands, Irwin Naturals, Earnings Call, Financial Results, Acquisition, Nutritional Supplements, E-commerce, Amazon